Feb. 14, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology
leader providing innovative cancer detection and therapy solutions, today
announced that it will release financial results for the fourth quarter and
year ended December 31, 2021, after the market close, and host a conference
call at 4:30 PM Eastern Time on Monday, February 28.
February 28th at 4:30 PM ET
in Nashua, NH, iCAD is a global medical technology leader providing innovative
cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Jessica Burns, iCAD
iCAD Investor Relations